Method and Assay for Early Diagnosis of Prostate Cancer

A method and assay are described for determining prostate cancer and the general stage of progression of such cancer by quantifying levels of promoter methylation of gal-3, optionally in combination with the quantification of the level of GSTP1 promoter methylation, where the method and assay are non-invasive to a subject and can detect any of Stages I-IV prostate cancer.

Patents:
US 20,090,215,066

Inventor(s): AHMED HAFIZ [US]; VASTA GERARDO RAUL [US]

Type of Offer: Licensing



« More Diagnostic Patents

---